EUVIMEDEUVIMED entdecken
Crossref

RNA‐Binding Protein DHX9 Enhances Radioresistance in Metastatic Hepatocellular Carcinoma by Activation of the PI3K/Akt Pathway Through Enhanced EEF1A2 mRNA Stability

HaiBo Wang, Wei Cui iD

Journal of Biochemical and Molecular Toxicology · 2025

DOI: 10.1002/jbt.70356 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biochemical and Molecular Toxicology, 2025. Verfasst von HaiBo Wang und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Imaging, The Affiliated People's Hospital of Ningbo University, Ningbo City, Zhejiang Province, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Peptide Elongation Factor 1, Liver Neoplasms, Proto-Oncogene Proteins c-akt. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 31 Literaturangaben. Gefördert von: The authors received no specific funding for this work..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study elucidated the role of Eukaryotic Elongation Factor 1 Alpha 2 (EEF1A2) and RNA‐binding protein DExH‐Box helicase 9 (DHX9) in hepatocellular carcinoma (HCC) radioresistance and molecular mechanisms. HCC tissues were compared with adjacent normal liver tissues by bioinformatics analysis. Clinical samples were evaluated according to RECIST 1.1 criteria. Regulatory interactions between EEF1A2 and DHX9 were analyzed. The effect of targeting these genes on HCC radioresistance was assessed. EEF1A2 was significantly elevated in radiation‐resistant HCC tissues and cell lines. EEF1A2 overexpression was associated with enhanced cellular proliferation, reduced apoptosis, increased metastatic potential. Decreasing EEF1A2 significantly improved radiosensitivity. DHX9 stabilized EEF1A2 mRNA and increased EEF1A2 expression. Inhibition of DHX9 produced similar radiosensitizing effects as those observed with EEF1A2 knockdown. The interaction between DHX9 and EEF1A2 activated the PI3K/Akt pathway. The DHX9/EEF1A2 axis plays a pivotal role in the radioresistance of HCC by modulating the PI3K/Akt pathway.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularPeptide Elongation Factor 1Liver NeoplasmsProto-Oncogene Proteins c-aktPhosphatidylinositol 3-KinasesDEAD-box RNA HelicasesRadiation ToleranceSignal TransductionRNA StabilityNeoplasm ProteinsRNA, NeoplasmHumansCell Line, TumorMaleNeoplasm MetastasisRNA, MessengerGene Expression Regulation, NeoplasticFemaleMiddle Aged

Stichwörter der Autor:innen

DHX9EEF1A2PI3K/Akt pathwayRadioresistancehepatocellular carcinoma

Substanzen

Peptide Elongation Factor 1Proto-Oncogene Proteins c-aktEEF1A2 protein, humanPhosphatidylinositol 3-KinasesDEAD-box RNA HelicasesDHX9 protein, humanNeoplasm ProteinsRNA, NeoplasmRNA, Messenger

Autor:innen und Institutionen

  • Department of Medical Imaging, The Affiliated People's Hospital of Ningbo University, Ningbo City, Zhejiang Province, China.

ORCID-Profile: Wei Cui

Förderung

  • The authors received no specific funding for this work.

Zitieren

APA

Wang, H., & Cui, W. (2025). RNA‐Binding Protein DHX9 Enhances Radioresistance in Metastatic Hepatocellular Carcinoma by Activation of the PI3K/Akt Pathway Through Enhanced EEF1A2 mRNA Stability. Journal of Biochemical and Molecular Toxicology. https://doi.org/10.1002/jbt.70356

Vancouver

Wang H, Cui W. RNA‐Binding Protein DHX9 Enhances Radioresistance in Metastatic Hepatocellular Carcinoma by Activation of the PI3K/Akt Pathway Through Enhanced EEF1A2 mRNA Stability. Journal of Biochemical and Molecular Toxicology. 2025. doi:10.1002/jbt.70356

BibTeX
@article{Wang2025,
  author = {Wang, HaiBo and Cui, Wei},
  title = {RNA‐Binding Protein DHX9 Enhances Radioresistance in Metastatic Hepatocellular Carcinoma by Activation of the PI3K/Akt Pathway Through Enhanced EEF1A2 mRNA Stability},
  journal = {Journal of Biochemical and Molecular Toxicology},
  year = {2025},
  doi = {10.1002/jbt.70356}
}
Kostenlos starten →